CHOLAHLDNG:NSECholamandalam Financial Holdings Ltd Analysis
Data as of 2026-05-16 - not real-time
₹1,658.00
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Cholamandalam Financial Holdings presents an attractive valuation profile, with its price multiple comfortably below the sector average. The company is delivering robust top‑line expansion, outpacing many peers in the credit services space. Despite this growth, the balance sheet remains heavily leveraged, with debt levels far exceeding equity. Operating cash generation is currently negative, raising questions about the sustainability of its financing model. The dividend policy is ultra‑conservative, paying a minimal portion of earnings, which supports dividend sustainability given the cash reserves. Overall, the fundamentals suggest a blend of value and growth characteristics.
Technically, the stock trades slightly above its short‑term moving average and exhibits a modest bullish MACD divergence. Momentum indicators such as the RSI sit in a neutral zone, while volume trends are picking up, hinting at renewed buying interest. However, price volatility remains elevated and the stock sits below its long‑term average, underscoring a cautious outlook. The low beta indicates limited market‑wide price swings, yet sector‑specific regulatory and liquidity concerns persist. Given the upside potential implied by current support and resistance levels, a measured buying approach is warranted. Investors should balance the appealing valuation against the pronounced leverage and cash flow challenges.
Technically, the stock trades slightly above its short‑term moving average and exhibits a modest bullish MACD divergence. Momentum indicators such as the RSI sit in a neutral zone, while volume trends are picking up, hinting at renewed buying interest. However, price volatility remains elevated and the stock sits below its long‑term average, underscoring a cautious outlook. The low beta indicates limited market‑wide price swings, yet sector‑specific regulatory and liquidity concerns persist. Given the upside potential implied by current support and resistance levels, a measured buying approach is warranted. Investors should balance the appealing valuation against the pronounced leverage and cash flow challenges.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- Bullish MACD signal
- Undervalued price relative to sector
- Increasing trading volume
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Strong revenue growth
- Attractive forward PE
- Low market beta
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- High leverage and negative cash flow
- Regulatory environment for credit services
- Sustainable but minimal dividend payout
Key Metrics & Analysis
Financial Health
Revenue Growth18.20%
Profit Margin9.69%
P/E Ratio12.8
ROE18.04%
ROA2.22%
Debt/Equity621.27
P/B Ratio2.0
Op. Cash Flow₹-300327698432
Industry P/E16.5
Technical Analysis
TrendNeutral
RSI52.7
Support₹1,519.90
Resistance₹1,809.90
MA 20₹1,644.57
MA 50₹1,562.76
MA 200₹1,769.88
MACDBullish
VolumeIncreasing
Fear & Greed Index88.52
Valuation
Target Price₹2,225.00
Upside/Downside34.20%
GradeUndervalued
TypeBlend
Dividend Yield0.08%
Risk Assessment
Beta0.42
Volatility56.56%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.